HKU Scholars Hub: Browsing DSpace

Browsing "Medicine: Journal/Magazine Articles" by Author jia, w

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 19 of 19

	Title	Author(s)	Issue Date
	Chronic vascular complications in diabetes Journal:Journal of diabetes research	Jia, W Xu, A Chen, A Wu, J Ye, J	2013
	Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans Journal:Clinical Chemistry	Yu, H Xia, F Lam, KSL Wang, Y Bao, Y Zhang, J Gu, Y Zhou, P Lu, J Jia, W Xu, A	2011
	Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure Journal:Clinical Science	Liu, M Zhou, M Bao, Y Xu, Z Li, H Zhang, H Zhu, W Zhang, J Xu, A Jia, W	2013
	Circulating fibroblast growth factor 21 Is a sensitive biomarker for severe ischemia/reperfusion injury in patients with liver transplantation Journal:Scientific Reports	Ye, D Li, H Wang, Y Jia, W Zhou, J Fan, J Man, K Lo, CM Wong, CM Wang, Y Lam, KSL Xu, A	2016
	Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction Journal:Clinical Science	Zhou, M Bao, Y Li, H Pan, Y Shu, L Xia, Z Wu, D Lam, KSL Vanhoutte, PMGR Xu, A Jia, W Hoo, RLC	2015
	Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat Journal:Nature Communications	Li, H Wu, G Fang, Q Zhang, M Hui, X Sheng, B Wu, L Bao, Y Li, P Xu, A Jia, W	2018
	Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride Journal:Journal of Hepatology	Li, H Fang, Q Gao, F Fan, J Zhou, J Wang, X Zhang, H Pan, X Bao, Y Xiang, K Xu, A Jia, W	2010
	Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice Journal:Hepatology	Ye, D Wang, Y Li, H Jia, W Man, K Lo, CM Wang, Y Lam, KSL Xu, A	2014
	High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China Journal:Journal of Hepatology	Li, H Dong, K Fang, Q Hou, X Zhou, M Bao, Y Xiang, K Xu, A Jia, W	2013
	Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose Journal:Scientific Reports	Zhang, J Li, H Zhou, H Fang, L Xu, J Yan, H Chen, S Song, Q Zhang, Y Xu, A Fang, Q Ye, Y Jia, W	2017
	Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis Journal:Diabetes/Metabolism Research and Reviews	Wu, J Li, H Zhou, M Fang, Q Bao, Y Xu, A Jia, W	2014
	Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study Journal:Diabetes Research and Clinical Practice	Ong, KL Wu, L Januszewski, AS O'Connell, RL Xu, A Rye, KA Ma, RCW Li, H Jenkins, AJ Jia, W Keech, AC	2020
	Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations Journal:Cell Metabolism	Ni, Y Qian, L Siliceo, SL Long, X Nychas, E Liu, Y Ismaiah, MJ Leung, H Zhang, L Gao, Q Wu, Q Zhang, Y Jia, X Liu, S Yuan, R Zhou, L Wang, X Li, Q Zhao, Y El-Nezami, H Xu, A Xu, G Li, H Panagiotou, G Jia, W	5-Sep-2023
	Risk assessment with gut microbiome and metabolite markers in NAFLD development Journal:Science Translational Medicine	Leung, H Long, X Ni, Y Qian, L Nychas, E Siliceo, SL Pohl, D Hanhineva, K Liu, Y Xu, A Nielsen, HB Belda, E Clément, K Loomba, R Li, H Jia, W Panagiotou, G	8-Jun-2022
	Serum fibroblast growth factor 19 levels are decreased in chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels Journal:Diabetes Care	Fang, Q Li, H Song, Q Yang, W Hou, X Ma, X Lu, J Xu, A Jia, W	2013
	Serum fibroblast growth factor 21 is associated with adverse lipid profiles and γ-glutamyltransferase but not insulin sensitivity in Chinese subjects Journal:Journal of Clinical Endocrinology and Metabolism	Li, H Bao, Y Xu, A Pan, X Lu, J Wu, H Lu, H Xiang, K Jia, W	2009
	Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI Journal:PLoS ONE	Tsai, VW Macia, L Feinle-Bisset, C Manandhar, R Astrup, A Raben, A Lorenzen, JK Schmidt, PT Wiklund, F Pedersen, NL Campbell, L Kriketos, A Xu, A Zhou, P Jia, W Curmi, PMG Angstmann, CN Lee-Ng, KKM Zhang, HP Marquis, CP Husaini, Y Beglinger, C Lin, S Herzog, H Brown, DA Sainsbury, A Breit, SN	2015
	Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3 Journal:Diabetes	Li, H Gao, Z Zhang, J Ye, X Xu, A Ye, J Jia, W	2012
	Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice Journal:Gut	Ye, D Li, FYL Lam, KSL Li, H Jia, W Wang, Y Man, K Lo, CM Li, X Xu, A	2012

Showing results 1 to 19 of 19